Edition:
United Kingdom

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,168.80INR
10:10am GMT
Change (% chg)

Rs6.65 (+0.31%)
Prev Close
Rs2,162.15
Open
Rs2,175.10
Day's High
Rs2,201.30
Day's Low
Rs2,159.00
Volume
35,276
Avg. Vol
53,299
52-wk High
Rs2,948.00
52-wk Low
Rs1,901.65

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Laboratories Launches Melphalan Hydrochloride Injection In U.S.
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS LAUNCH OF MELPHALAN HYDROCHLORIDE FOR INJECTION IN U.S. MARKET.  Full Article

Dr.Reddy's Labs Disagrees' With U.S. Govt. Allegations On Drug Packaging Not Tested For Child Safety
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Dr.Reddy's Laboratories Ltd ::DR.REDDY'S LABORATORIES 'FIRMLY DISAGREES' WITH U.S. GOVERNMENT ALLEGATIONS THAT CO SOLD PRESCRIPTION DRUGS IN U.S. IN PACKAGING NOT TESTED FOR CHILD SAFETY.NOT AWARE OF REPORTS THAT PRODUCTS CAUSED CHILDREN HARM AS A RESULT OF PACKAGING.  Full Article

Dr.Reddy's Labs Gets EIR From U.S. FDA ‍​For Facility In Hyderabad
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GETS EIR FROM U.S. FDA ‍​FOR CUSTOM PHARMA SERVICES FACILITY IN HYDERABAD.  Full Article

Dr.Reddy's Labs Gets U.S. FDA Nod For Psoriasis Treatment
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS CO, THROUGH UNIT, GETS NDA NOD FOR PSORIASIS TREATMENT.  Full Article

Dr.Reddy's Laboratories gets German Regulator's Nod For CAPA Plan
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GERMANY REGULATOR APPROVES CO'S CAPA PLAN.SAYS GERMAN REGULATOR PERMITTED PRODUCTION TO START AGAIN FROM FACILITY FOR EU MARKET‍​.SAYS GERMANY REGULATOR TO RE-INSPECT DUVVADA FACILITY BY END-2018.  Full Article

Dr.Reddy's Laboratories gets EIR from US FDA for Duvvada facility
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Dr.Reddy's Laboratories Ltd ::Says got EIR from US FDA for formulations manufacturing facility at Duvvada, Vishakhapatnam‍​.Says FDA has explained that the inspection has not closed and site's status remains unchanged.Planning to request a re-inspection in 2018.  Full Article

Dr.Reddy's Labs ‍launches clofarabine injection in U.S.
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Dr.Reddy's Laboratories Ltd ::Says ‍launch of clofarabine injection in U.S. market​.  Full Article

DR. REDDY'S LABORATORIES LAUNCHES GENERIC AZACITIDINE FOR INJECTION IN CANADIAN MARKET
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Dr.Reddy's Laboratories Ltd :DR REDDY'S LABORATORIES ANNOUNCES THE LAUNCH OF GENERIC AZACITIDINE FOR INJECTION IN THE CANADIAN MARKET.GENERIC AZACITIDINE FOR INJECTION 100 MG/VIAL, A BIOEQUIVALENT GENERIC VERSION OF VIDAZA IS APPROVED BY HEALTH CANADA​.  Full Article

India's Dr.Reddy's Laboratories Sept-qtr consol PAT down about 1 pct
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Dr.Reddy's Laboratories Ltd ::Sept quarter consol net profit after tax 3.05 billion rupees versus 3.09 billion rupees last year.Consensus forecast for sept quarter consol profit was 2.88 billion rupees.Sept quarter consol net sales 34.91 billion rupees versus 35.29 billion rupees last year.Expect to see results from products launched in U.S. during first half of the fiscal‍​.  Full Article

Dr Reddy's says U.S. court finds co's product infringes some patents
Thursday, 16 Feb 2017 

Dr.Reddy's Laboratories Ltd : Says Dr. Reddy's Laboratories announces U.S. district court's opinion relating to patent infringement . Court found that asserted claims of the "094" and "980" patents were not invalid .Court found that co's proposed palonosetron hydrochloride product infringes certain claims of some U.S. patents.  Full Article

BRIEF-Dr.Reddy's Laboratories Says Amended Complaint w.r.t U.S. Class Action Lawsuit Filed

* W.R.T U.S. CLASS ACTION LAWSUIT, AMENDED COMPLAINT FILED BY PLAINTIFF WHERE CHAIRMAN, COO AND U.S. UNIT ADDED AS DEFENDANTS Source text - http://bit.ly/2CvdcnN Further company coverage: